ACTIVE

Alcon Laboratories Belgium

Financial year 2025 · Closed on 31/12/2025

Net result4,4 M €+9,8 %over 1 year
Revenue169,7 M €+2,0 %over 1 year
Equity26,6 M €+19,9 %over 1 year
Workforce401,8 ETP+4,4 %over 1 year

Identity

Source · BCE/KBO

Alcon Laboratories Belgium is a Private limited company incorporated in 2010. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Puurs-Sint-Amands. It employs on average 401,8 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0830.069.679
Incorporation
04/10/2010
Legal form
Private limited company
Registered office
Lichterveld 3
2870 Puurs-Sint-Amands · FlandreSee on map
Contributed capital
18 550,00 €
Latest accounts
31/12/2025
Average workforce
401,8 ETP
Joint committees (2)
  • 116
  • 207
Signals
ProfitablePositive cashflowPositive EBITDAHealthy social debtsHigh revenue

Financials

Source · NBB, 15 filings

Trend over 10 financial years

20252024202320222021
Income statement
Revenue169,7 M €166,5 M €171,6 M €159,6 M €130,6 M €
EBITDA10,7 M €8,3 M €10,3 M €9,8 M €8 M €
Operating result6,1 M €5,7 M €6,1 M €5,5 M €4,5 M €
Net result4,4 M €4 M €4,3 M €3,7 M €3,1 M €
Balance sheet
Equity26,6 M €22,2 M €18,1 M €13,8 M €10,1 M €
Total assets107,2 M €89,3 M €80,9 M €71,2 M €58 M €
Cash–––––
Debts79,7 M €66,7 M €62,1 M €56,8 M €47,5 M €
Other
Workforce401,8 ETP385,0 ETP394,1 ETP403,8 ETP408,0 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 50 M€ and 100 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

4 active · 6 ended

Active mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
Jason Mangum
Directorsince 01/12/2025
Liesbeth Tack
Directorsince 01/08/2024
Gerald Patrick Collier
Director10/07/2022 → 30/11/2025
Yannick Cools
Directorsince 28/01/2021

Ended mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
Caroline Loquet
Chairman of the board of directors01/01/2019 → 31/07/2024
Chris Olson
Director01/01/2019 → 2021 accounts
Johan MANGELSCHOTS
Director01/01/2019 → 2019 accounts

Full financial information

Source · NBB
202520242023202220212020
Type of accountFull modelFull modelFull modelFull modelFull modelFull model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date02/07/202607/07/202525/07/202430/06/202308/07/202228/07/2021
General meeting30/06/202630/06/202528/06/202430/06/202308/07/202209/07/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 15 filings
ModelClosingGeneral meetingFiledLanguageDocument
Full model31/12/202530/06/202602/07/2026DutchPDF
Full model31/12/202430/06/202507/07/2025DutchPDF
Full model31/12/202328/06/202425/07/2024DutchPDF
Full model31/12/202230/06/202330/06/2023DutchPDF
Full model31/12/202108/07/202208/07/2022DutchPDF
Full model31/12/202009/07/202128/07/2021DutchPDF
Full model31/12/201926/06/202029/06/2020DutchPDF
Full model31/12/201818/10/201922/10/2019DutchPDF
Full model31/12/201728/08/201826/09/2018DutchPDF
Full model31/12/201630/06/201720/07/2017DutchPDF
Full model31/12/201526/04/201607/11/2016DutchPDF
Full model31/12/201407/09/201501/10/2015DutchPDF
Full model31/12/201327/05/201427/06/2014DutchPDF
Full model31/12/201212/09/201315/10/2013DutchPDF
Full model31/12/201128/05/201315/10/2013DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 50 M€ and 100 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

4 active · 6 ended

Active mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
Jason Mangum
Directorsince 01/12/2025
Liesbeth Tack
Directorsince 01/08/2024
Gerald Patrick Collier
Director10/07/2022 → 30/11/2025
Yannick Cools
Directorsince 28/01/2021

Ended mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
Caroline Loquet
Chairman of the board of directors01/01/2019 → 31/07/2024
Chris Olson
Director01/01/2019 → 2021 accounts
Johan MANGELSCHOTS
Director01/01/2019 → 2019 accounts

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Other18/09/2026
    Wijziging vaste vertegenwoordiger commissaris
    PDF
  • Mandates16/12/2025
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates24/12/2024
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates13/09/2024
    WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN - ALGEMENE VERGADERING
    PDF
  • Mandates27/03/2023
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates23/09/2022
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates04/06/2021
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates04/03/2021
    ONTSLAGEN - BENOEMINGEN
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts
Year
Identity
Incorporation
Name
Registered office
Annual accounts
Filings10 filings
Mandates
Jason Mangum
Liesbeth Tack
Gerald Patrick Collier
Yannick Cools
Caroline Loquet
Chris Olson
Johan MANGELSCHOTS
Ian BELL
Knut MAGER
Dario DRAGO
20102011201220132014201520162017201820192020202120222023202420252026
Alcon Laboratories Belgium
Lichterveld 3, 2870 Puurs-Sint-Amands
Director
Director
Director
Chairman of the board of directors
Director
Director
Director
Chairman of the board of directors
CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE
Registered addressPeriodSource
Lichterveld 3, 2870 Puurs-Sint-AmandsCurrent
accounts 2021 → 2025
Accounts 2025 · 2026-00236187

Company names

Source · NBB annual accounts, CBE
NamePeriodSource
Alcon Laboratories BelgiumCurrent
accounts 2015 → 2025
Accounts 2025 · 2026-00236187

Events

  1. 2025
    Annual accounts 20254,4 M €↑
  2. 01/12/2025
    nominationJason Mangum · bestuurder
  3. 2024
    Annual accounts 20244 M €↓
  4. 03/09/2024
    reconductionCOOLS Yannick Arlette Albert · bestuurder
  5. 03/09/2024
    reconductionCOLLIER Gerald Patrick · bestuurder
  6. 03/09/2024
    nominationTACK Liesbeth Marie Hector · niet-statutaire bestuurder
  7. 03/09/2024
    nominationCOOLS Yannick Arlette Albert · lid van de Groep A
  8. 03/09/2024
    nominationGORDTS Hans Emiel · lid van de Groep B
  9. 03/09/2024
    nominationHERMANS Hilde Josee Paula · lid van de Groep B
  10. 03/09/2024
    nominationVAN DYCK Louis Leon Lieve · lid van de Groep B
  11. 28/06/2024
    nominationSofie Van Grieken · commissaris
  12. 2023
    Annual accounts 20234,3 M €↑
  13. 23/02/2023
    nominationHilde Hermans · externe vertegenwoordiger behorende tot de groep B
  14. 23/02/2023
    nominationLouis Van Dyck · externe vertegenwoordiger behorende tot de groep B
  15. 2022
    Annual accounts 20223,7 M €↑
  16. 10/07/2022
    nominationGerald Patrick Collier · bestuurder
  17. 2021
    Annual accounts 20213,1 M €↓
  18. 2020
    Annual accounts 20203,2 M €↓
  19. 2019
    Annual accounts 20193,8 M €↑
  20. 2017
    Annual accounts 20171,8 k €↓
  21. 2016
    Annual accounts 20161,8 k €↑
  22. 2015
    Annual accounts 20151,6 k €
  23. 04/10/2010
    IncorporationPrivate limited company